Snowball logo
logo
ITCI

Intra-Cellular Therapies, Inc

-- $$0.00Β  (0%)
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Intra-Cellular Therapies, Inc (ITCI) operate in?

Intra-Cellular Therapies, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Intra-Cellular Therapies, Inc (ITCI) Earnings Per Share (EPS)?

The trailing EPS is -$0.73, and the forward EPS is $3.13.

What is Intra-Cellular Therapies, Inc (ITCI) EBITDA?

Intra-Cellular Therapies, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -29.09 million.

Does Intra-Cellular Therapies, Inc (ITCI) dividends?

No. Intra-Cellular Therapies, Inc does not pay a dividend.

How did Intra-Cellular Therapies, Inc (ITCI) perform in its most recent earnings report?

In the last report (December 31, 2024), Intra-Cellular Therapies, Inc posted an EPS surprise of -44.27% and a revenue surprise of -70.48%.

When is Intra-Cellular Therapies, Inc (ITCI) next earnings report?

Intra-Cellular Therapies, Inc is expected to release its next earnings report on March 31, 2025.